Benchmark Reiterates Buy Rating on agilon health Inc (AGL)
Tweet Send to a Friend
Benchmark analyst Bill Sutherland reiterated a Buy rating and $1.50 price target on agilon health Inc (NYSE: AGL).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


